From GlobeNewswire: 2025-06-17 23:15:00

Biomea Fusion, Inc. announced the pricing of a public offering consisting of 19,450,000 shares of common stock and warrants, with a potential additional purchase option. The offering is expected to raise approximately $40 million and is set to close on June 20, 2025. Jefferies is the sole book-running manager for the offering. The company is offering the securities pursuant to an effective shelf registration statement filed with the SEC. Biomea Fusion is a clinical-stage diabetes and obesity medicines company focused on developing oral small molecules to improve the lives of patients with metabolic diseases.



Read more at GlobeNewswire: Biomea Fusion Announces Pricing of Public Offering of